New test helps doctors ID kidney disease cause

(HealthDay)—A new test that helps doctors identify the cause of a specific type of kidney disease has been approved by the U.S. Food and Drug Administration.

Membranous glomerulonephritis (MGN) damages blood vessels in the kidneys that help filter the blood. Some cases are caused by the body's rejection of its own (autoimmune), while the rest are triggered by other causes such as infection, the FDA said in a news release.

The Euroimmun Anti- Pla2r IFA test detects an antibody that is present if the cause of MGN is autoimmune, the FDA said.

In a clinical study of 560 blood samples, the test detected autoimmune cases of MGN in 77 percent of samples donated by people presumed to have this form, the agency said.

The test should not be the sole determinant of MGN's cause, nor should a negative test rule out a specific cause, the FDA said.

The test is manufactured by Euroimmun US, based in Morris Plains, N.J.

More information: Visit the FDA to learn more.

add to favorites email to friend print save as pdf

Related Stories

New test IDs genotype of hepatitis C

Jun 20, 2013

(HealthDay)—A new test to help doctors identify the genotype of a person's hepatitis C infection has been approved by the U.S. Food and Drug Administration.

Recommended for you

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.